Literature DB >> 17499995

Modification in reverse: the SUMO proteases.

Debaditya Mukhopadhyay1, Mary Dasso.   

Abstract

SUMOs (small ubiquitin-like modifiers) are ubiquitin-related proteins that become covalently conjugated to cellular target proteins that are involved in a variety of processes. Frequently, this modification has a key role in regulating the activities of those targets and, thus, their cellular functions. SUMO conjugation is a highly dynamic process that can be rapidly reversed by the action of members of the Ubl (ubiquitin-like protein)-specific protease (Ulp) family. The same family of enzymes is also responsible for maturation of newly synthesized SUMOs prior to their initial conjugation. Recent advances in structural, biochemical and cell biological analysis of Ulp/SENPs reveal their high degree of specificity towards SUMO paralogs, in addition to discrimination between processing, deconjugation and chain-editing reactions. The dissimilar sub-nuclear localization patterns of Ulp/SENPs and phenotypes of Ulp/SENP mutants further indicate that different Ulp/SENPs have distinct and non-redundant roles.

Mesh:

Substances:

Year:  2007        PMID: 17499995     DOI: 10.1016/j.tibs.2007.05.002

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  250 in total

1.  Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.

Authors:  Anja Büchner; Petranka Krumova; Sundar Ganesan; Mathias Bähr; Katrin Eckermann; Jochen H Weishaupt
Journal:  Neuromolecular Med       Date:  2014-11-13       Impact factor: 3.843

Review 2.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on Midleg.

Authors:  Matthew Smith; Daniel R Mallin; Jeffrey A Simon; Albert J Courey
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

Review 4.  Trojan horse strategies used by pathogens to influence the small ubiquitin-like modifier (SUMO) system of host eukaryotic cells.

Authors:  Miklós Békés; Marcin Drag
Journal:  J Innate Immun       Date:  2012-01-03       Impact factor: 7.349

5.  A new class of SUMO proteases.

Authors:  Jennifer Gillies; Mark Hochstrasser
Journal:  EMBO Rep       Date:  2012-04-02       Impact factor: 8.807

Review 6.  The fate of metaphase kinetochores is weighed in the balance of SUMOylation during S phase.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Cell Cycle       Date:  2010-08-09       Impact factor: 4.534

7.  The SUMO conjugation pathway in Populus: genomic analysis, tissue-specific and inducible SUMOylation and in vitro de-SUMOylation.

Authors:  Jon M Reed; Christopher Dervinis; Alison M Morse; John M Davis
Journal:  Planta       Date:  2010-04-02       Impact factor: 4.116

8.  The SUMO pathway functions in mouse oocyte maturation.

Authors:  Zhen-Bo Wang; Xiang-Hong Ou; Jing-Shan Tong; Sen Li; Liang Wei; Ying-Chun Ouyang; Yi Hou; Heide Schatten; Qing-Yuan Sun
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 9.  SUMO: a multifaceted modifier of chromatin structure and function.

Authors:  Caelin Cubeñas-Potts; Michael J Matunis
Journal:  Dev Cell       Date:  2013-01-14       Impact factor: 12.270

10.  SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.

Authors:  Seong Won Lee; Moon Hee Lee; Jong Ho Park; Sung Hwan Kang; Hee Min Yoo; Seung Hyun Ka; Young Mi Oh; Young Joo Jeon; Chin Ha Chung
Journal:  EMBO J       Date:  2012-10-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.